Stay updated on SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.3%
    Check dated 2025-09-14T18:51:33.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.3%
    Check dated 2025-09-07T13:38:15.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and country listings. These changes enhance the clarity and relevance of the page's content.
    Difference
    100%
    Check dated 2025-08-31T11:35:44.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-17T00:58:46.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T19:55:31.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about a clinical trial for non-small cell lung cancer, including its title, sponsor, and last update date. Additionally, the page emphasizes that the U.S. government does not review or approve all studies listed.
    Difference
    81%
    Check dated 2025-08-02T14:42:29.000Z thumbnail image

Stay in the know with updates to SBRT +/- Pembrolizumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT +/- Pembrolizumab in NSCLC Clinical Trial page.